Test Price
2,800 AEDโ Home Collection Available
GABRA1 Gene (Early Infantile Epileptic Encephalopathy Type 19) Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
Executive Summary: High-precision genetic screening for early infantile epileptic encephalopathy caused by GABRA1 mutations, achieving 99.9% diagnostic sensitivity. This DHA-accredited NGS test is supported by VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection, with telephonic post-test clinical guidance from DHA-licensed genetic counsellors.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-Licensed Genetic Counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GABRA1 NGS test is a definitive molecular diagnostic tool for early infantile epileptic encephalopathy type 19 (EIEE19). Using next-generation sequencing, it identifies pathogenic variants in the GABRA1 gene with unmatched precision, guiding targeted therapeutic decisions and genetic counselling in the UAE.
| Feature | Our Test (DHA-Accredited NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full gene coverage | ~95% sensitivity; limited to known hotspots |
| Methodology | NGS (Next Generation Sequencing) with CNV analysis | Capillary electrophoresis Sanger |
| Turnaround Time | 3 โ 4 Weeks | 6 โ 8 Weeks |
| Pre-Test Requirement | Genetic counselling & pedigree chart (included in service) | Often omitted |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Genetics, I have witnessed how a precise GABRA1 diagnosis transforms a familyโs journey from uncertainty to a tailored care plan. Genetic results must always be correlated with clinical findings by a paediatric epileptologist. Never stop or adjust antiseizure medications without direct specialist supervision.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA No. 9294403
โ ๏ธ Medication Safety Advisory
Do not discontinue prescribed antiepileptic drugs or any other medication without explicit instructions from your treating physician. Abrupt withdrawal can provoke life-threatening seizure exacerbation.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active febrile illness within 48 hours (may reschedule collection).
- Exclusion: Known coagulopathy or severe thrombocytopenia โ discuss with our phlebotomist before draw.
- Red Flag: New-onset prolonged seizure (>5 min) or status epilepticus โ proceed immediately to the nearest Emergency Department.
- Red Flag: Signs of raised intracranial pressure (vomiting, lethargy, bulging fontanelle in infants) โ seek urgent paediatric neurological care before testing.
Patient FAQ & Clinical Guidance
1. What is the GABRA1 gene test for?
The GABRA1 NGS test detects pathogenic mutations in the GABRA1 gene that cause early infantile epileptic encephalopathy type 19 (EIEE19), a severe neonatal epilepsy syndrome. Results help confirm diagnosis and guide tailored treatment and genetic counselling.
2. Do I need a doctorโs referral?
Yes, a referral from a DHA-licensed neurologist or paediatrician is mandatory to ensure appropriate pre-counselling and interpretation of results. Our genetic counsellors can coordinate with your physician.
3. How is the sample collected and what is the turnaround time?
A certified phlebotomist collects a small blood sample (whole blood in EDTA tube or FTA card) at your home or in our facility. Results are ready in 3โ4 weeks via secure digital report.
4. Is genetic counselling included?
Yes, pre-test and post-test genetic counselling by DHA-licensed professionals is included. We also provide a detailed pedigree analysis when family history is available.
UAE Regulatory & Data Privacy Adherence
This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Your genetic data is encrypted, handled by trained professionals, and never shared without your explicit consent in accordance with UAE privacy laws.
Clinical & Logistical Metadata
| Test Name | GABRA1 Gene (Early Infantile Epileptic Encephalopathy Type 19) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | G40.4 |
| LOINC Code | 21614-4 |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians